Cargando…

EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth

OBJECTIVE: To determine whether the variation in neurodevelopmental disability rates between populations persists after adjustment for demographic, maternal and infant characteristics for an international very preterm (VPT) birth cohort using a standardised approach to neurodevelopmental assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Draper, Elizabeth S, Zeitlin, Jennifer, Manktelow, Bradley N, Piedvache, Aurelie, Cuttini, Marina, Edstedt Bonamy, Anna-Karin, Maier, Rolf, Koopman-Esseboom, Corine, Gadzinowski, Janusz, Boerch, Klaus, van Reempts, Patrick, Varendi, Heili, Johnson, Samantha J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363786/
https://www.ncbi.nlm.nih.gov/pubmed/31690558
http://dx.doi.org/10.1136/archdischild-2019-317418
_version_ 1783559707100708864
author Draper, Elizabeth S
Zeitlin, Jennifer
Manktelow, Bradley N
Piedvache, Aurelie
Cuttini, Marina
Edstedt Bonamy, Anna-Karin
Maier, Rolf
Koopman-Esseboom, Corine
Gadzinowski, Janusz
Boerch, Klaus
van Reempts, Patrick
Varendi, Heili
Johnson, Samantha J
author_facet Draper, Elizabeth S
Zeitlin, Jennifer
Manktelow, Bradley N
Piedvache, Aurelie
Cuttini, Marina
Edstedt Bonamy, Anna-Karin
Maier, Rolf
Koopman-Esseboom, Corine
Gadzinowski, Janusz
Boerch, Klaus
van Reempts, Patrick
Varendi, Heili
Johnson, Samantha J
author_sort Draper, Elizabeth S
collection PubMed
description OBJECTIVE: To determine whether the variation in neurodevelopmental disability rates between populations persists after adjustment for demographic, maternal and infant characteristics for an international very preterm (VPT) birth cohort using a standardised approach to neurodevelopmental assessment at 2 years of age. DESIGN: Prospective standardised cohort study. SETTING: 15 regions in 10 European countries. PATIENTS: VPT births: 22(+0)–31(+6) weeks of gestation. DATA COLLECTION: Standardised data collection tools relating to pregnancy, birth and neonatal care and developmental outcomes at 2 years corrected age using a validated parent completed questionnaire. MAIN OUTCOME MEASURES: Crude and standardised prevalence ratios calculated to compare rates of moderate to severe neurodevelopmental impairment between regions grouped by country using fixed effects models. RESULTS: Parent reported rates of moderate or severe neurodevelopmental impairment for the cohort were: 17.3% (ranging 10.2%–26.1% between regions grouped by country) with crude standardised prevalence ratios ranging from 0.60 to 1.53. Adjustment for population, maternal and infant factors resulted in a small reduction in the overall variation (ranging from 0.65 to 1.30). CONCLUSION: There is wide variation in the rates of moderate to severe neurodevelopmental impairment for VPT cohorts across Europe, much of which persists following adjustment for known population, maternal and infant factors. Further work is needed to investigate whether other factors including quality of care and evidence-based practice have an effect on neurodevelopmental outcomes for these children.
format Online
Article
Text
id pubmed-7363786
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73637862020-07-16 EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth Draper, Elizabeth S Zeitlin, Jennifer Manktelow, Bradley N Piedvache, Aurelie Cuttini, Marina Edstedt Bonamy, Anna-Karin Maier, Rolf Koopman-Esseboom, Corine Gadzinowski, Janusz Boerch, Klaus van Reempts, Patrick Varendi, Heili Johnson, Samantha J Arch Dis Child Fetal Neonatal Ed Original Research OBJECTIVE: To determine whether the variation in neurodevelopmental disability rates between populations persists after adjustment for demographic, maternal and infant characteristics for an international very preterm (VPT) birth cohort using a standardised approach to neurodevelopmental assessment at 2 years of age. DESIGN: Prospective standardised cohort study. SETTING: 15 regions in 10 European countries. PATIENTS: VPT births: 22(+0)–31(+6) weeks of gestation. DATA COLLECTION: Standardised data collection tools relating to pregnancy, birth and neonatal care and developmental outcomes at 2 years corrected age using a validated parent completed questionnaire. MAIN OUTCOME MEASURES: Crude and standardised prevalence ratios calculated to compare rates of moderate to severe neurodevelopmental impairment between regions grouped by country using fixed effects models. RESULTS: Parent reported rates of moderate or severe neurodevelopmental impairment for the cohort were: 17.3% (ranging 10.2%–26.1% between regions grouped by country) with crude standardised prevalence ratios ranging from 0.60 to 1.53. Adjustment for population, maternal and infant factors resulted in a small reduction in the overall variation (ranging from 0.65 to 1.30). CONCLUSION: There is wide variation in the rates of moderate to severe neurodevelopmental impairment for VPT cohorts across Europe, much of which persists following adjustment for known population, maternal and infant factors. Further work is needed to investigate whether other factors including quality of care and evidence-based practice have an effect on neurodevelopmental outcomes for these children. BMJ Publishing Group 2020-07 2019-11-05 /pmc/articles/PMC7363786/ /pubmed/31690558 http://dx.doi.org/10.1136/archdischild-2019-317418 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Draper, Elizabeth S
Zeitlin, Jennifer
Manktelow, Bradley N
Piedvache, Aurelie
Cuttini, Marina
Edstedt Bonamy, Anna-Karin
Maier, Rolf
Koopman-Esseboom, Corine
Gadzinowski, Janusz
Boerch, Klaus
van Reempts, Patrick
Varendi, Heili
Johnson, Samantha J
EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title_full EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title_fullStr EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title_full_unstemmed EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title_short EPICE cohort: two-year neurodevelopmental outcomes after very preterm birth
title_sort epice cohort: two-year neurodevelopmental outcomes after very preterm birth
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363786/
https://www.ncbi.nlm.nih.gov/pubmed/31690558
http://dx.doi.org/10.1136/archdischild-2019-317418
work_keys_str_mv AT draperelizabeths epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT zeitlinjennifer epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT manktelowbradleyn epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT piedvacheaurelie epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT cuttinimarina epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT edstedtbonamyannakarin epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT maierrolf epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT koopmanesseboomcorine epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT gadzinowskijanusz epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT boerchklaus epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT vanreemptspatrick epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT varendiheili epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT johnsonsamanthaj epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth
AT epicecohorttwoyearneurodevelopmentaloutcomesafterverypretermbirth